Appeals Court Finds Fosamax Lawsuits Over Femur Fractures Are Not Preempted
Fosamax femur fracture lawsuits will be returned to the U.S. District Court in New Jersey, where the litigation was consolidated more than 13 years ago.
Fosamax femur fracture lawsuits will be returned to the U.S. District Court in New Jersey, where the litigation was consolidated more than 13 years ago.
FDA urges doctors to avoid implanting new patients with the Zimmer Biomet CPT hip replacement system unless no other alternatives are available.
The FDA rejected an effort by Merck to add new Fosamax fracture label warnings in 2009, a federal judge determined.